Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Vita Life Sciences Limited ( (AU:VLS) ) is now available.
Vita Life Sciences Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back of ordinary fully paid shares under code VLS. The update, dated 20 March 2026, confirms that a total of 710,575 shares had been repurchased before the previous trading day, with a further 11,404 shares bought back on that day.
The company’s continued daily reporting of buy-back activity indicates an active capital management program aimed at reducing the number of shares on issue. This may support earnings per share and signal management’s confidence in the company’s valuation, with implications for existing shareholders through potential enhancement of ownership concentration and capital structure efficiency.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited is an ASX-listed company trading under the code VLS, with its ordinary fully paid shares the primary class of securities on issue. The business operates within the broader life sciences sector, though this filing focuses on its capital management activities rather than specific products, services, or markets.
Average Trading Volume: 14,270
Technical Sentiment Signal: Buy
Current Market Cap: A$136.2M
Find detailed analytics on VLS stock on TipRanks’ Stock Analysis page.